“We are increasing our investment in vaccines, and we will develop a seasonal flu vaccine, given the unmet need for highly effective vaccines,” CEO Stephane Bancel said in a news release.
The drugmaker said vaccines typically reduce the risk of getting the flu by 40 percent to 60 percent and that high-risk groups would benefit from a flu shot with higher efficacy.
Between 9 million and 45 million people in the U.S. have died of the flu annually since 2010, according to the CDC.
Read the full news release here.
More articles on pharmacy:
Drug costs surge faster than any other medical good or service, data shows
Eli Lilly, Amgen partner to make Lilly’s COVID-19 antibody drug
Moderna will know if COVID-19 vaccine is effective in November, CEO says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
